Adrian TE, Allen JM, Bloom SR, Ghatei MA, Rossor MN, Roberts GW, Crow TJ, Tatemoto K, Polak JM (1983) Neuropeptide Y distribution in human brain. Nature 306(5943):584–586. http://www.ncbi.nlm.nih.gov/pubmed/6358901

Article  CAS  PubMed  Google Scholar 

Bangasser DA, Curtis A, Reyes BA, Bethea TT, Parastatidis I, Ischiropoulos H, Van Bockstaele EJ, Valentino RJ (2010) Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry 15(9):877, 896–904. https://doi.org/10.1038/mp.2010.66

Article  CAS  Google Scholar 

Bangasser DA, Wiersielis KR, Khantsis S (2016) Sex differences in the locus coeruleus-norepinephrine system and its regulation by stress. Brain Res 1641(Pt B) 177–188. https://doi.org/10.1016/j.brainres.2015.11.021

Article  CAS  PubMed  Google Scholar 

Bertocchi I, Oberto A, Longo A, Mele P, Sabetta M, Bartolomucci A, Palanza P, Sprengel R, Eva C (2011) Regulatory functions of limbic Y1 receptors in body weight and anxiety uncovered by conditional knockout and maternal care. Proc Natl Acad Sci U S A 108(48):19395–19400

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blomqvist AG, Herzog H (1997) Y-receptor subtypes–how many more? Trends Neurosci 20(7):294–298. https://doi.org/10.1016/s0166-2236(96)01057-0

Article  CAS  PubMed  Google Scholar 

Bose M, Farias Quipildor G, Ehrlich ME, Salton SR (2022) Intranasal peptide therapeutics: a promising avenue for overcoming the challenges of traditional CNS drug development. Cells 11(22). https://doi.org/10.3390/cells11223629

Boublik JH, Scott NA, Brown MR, Rivier JE (1989) Synthesis and hypertensive activity of neuropeptide Y fragments and analogues with modified N- or C-termini or D-substitutions. J Med Chem 32(3):597–601. https://doi.org/10.1021/jm00123a014

Article  CAS  PubMed  Google Scholar 

Breslau N (2002) Gender differences in trauma and posttraumatic stress disorder. J Gend Specif Med 5(1):34–40. http://www.ncbi.nlm.nih.gov/pubmed/11859685

PubMed  Google Scholar 

Broqua P, Wettstein JG, Rocher MN, Gauthier-Martin B, Junien JL (1995) Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav Pharmacol 6(3):215–222. https://www.ncbi.nlm.nih.gov/pubmed/11224329

Article  CAS  PubMed  Google Scholar 

Butcher RL, Collins WE, Fugo NW (1974) Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology 94(6):1704–1708. https://doi.org/10.1210/endo-94-6-1704

Article  CAS  PubMed  Google Scholar 

Carobrez AP, Bertoglio LJ (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29(8):1193–1205. https://doi.org/10.1016/j.neubiorev.2005.04.017

Article  CAS  PubMed  Google Scholar 

Cohen H, Zohar J (2004) An animal model of posttraumatic stress disorder: the use of cut-off behavioral criteria. Ann N Y Acad Sci 1032:167–178. https://doi.org/10.1196/annals.1314.014

Article  PubMed  Google Scholar 

Cohen H, Liu T, Kozlovsky N, Kaplan Z, Zohar J, Mathé AA (2012) The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 37(2):350–363. https://doi.org/10.1038/npp.2011.230

Article  CAS  PubMed  Google Scholar 

Curtis AL, Bethea T, Valentino RJ (2006) Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Neuropsychopharmacology 31(3):544–554. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16123744

Article  CAS  PubMed  Google Scholar 

Decressac M, Barker RA (2012) Neuropeptide Y and its role in CNS disease and repair. Exp Neurol 238(2):265–272. https://doi.org/10.1016/j.expneurol.2012.09.004

Article  CAS  PubMed  Google Scholar 

Dhuria SV, Hanson LR, Frey WH (2010) Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99(4):1654–1673. https://doi.org/10.1002/jps.21924

Article  CAS  PubMed  Google Scholar 

Domin H (2021) Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies. Prog Neuropsychopharmacol Biol Psychiatry 111:110349. https://doi.org/10.1016/j.pnpbp.2021.110349

Article  CAS  PubMed  Google Scholar 

Duarte-Neves J, de Almeida P, L., Cavadas C (2016) Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases. Neurobiol Dis 95:210–224. https://doi.org/10.1016/j.nbd.2016.07.022

Article  CAS  PubMed  Google Scholar 

Enman NM, Sabban EL, McGonigle P, Van Bockstaele EJ (2015) Targeting the Neuropeptide Y System in Stress-related Psychiatric Disorders. Neurobiol Stress 1:33–43. https://doi.org/10.1016/j.ynstr.2014.09.007

Article  PubMed  PubMed Central  Google Scholar 

Gøtzsche CR, Woldbye DP (2016) The role of NPY in learning and memory. Neuropeptides 55:79–89. https://doi.org/10.1016/j.npep.2015.09.010

Article  CAS  PubMed  Google Scholar 

Heilig M, Söderpalm B, Engel JA, Widerlöv E (1989) Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 98(4):524–529. http://www.ncbi.nlm.nih.gov/pubmed/2570434

Article  CAS  PubMed  Google Scholar 

Heilig M, McLeod S, Brot M, Heinrichs SC, Menzaghi F, Koob GF, Britton KT (1993) Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8(4):357–363. http://www.ncbi.nlm.nih.gov/pubmed/8099792

Article  CAS  PubMed  Google Scholar 

Heilig M, Koob GF, Ekman R, Britton KT (1994) Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 17(2):80–85

Article  CAS  PubMed  Google Scholar 

Herzog H (2012) 30Years of NPY research. Neuropeptides 46(6):251. https://doi.org/10.1016/j.npep.2012.10.002

Article  CAS  PubMed  Google Scholar 

Herzog H, Hort YJ, Ball HJ, Hayes G, Shine J, Selbie LA (1992) Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci U S A 89(13):5794–5798. https://doi.org/10.1073/pnas.89.13.5794

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong SY, Oh JE, Lee KH (1999) Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. Biochem Pharmacol 58(11):1775–1780. https://doi.org/10.1016/s0006-2952(99)00259-2

Article  CAS  PubMed  Google Scholar 

Hourani L, Williams J, Bray R, Kandel D (2015) Gender differences in the expression of PTSD symptoms among active duty military personnel. J Anxiety Disord 29:101–108. https://doi.org/10.1016/j.janxdis.2014.11.007

Article  PubMed  Google Scholar 

Kask A, Harro J, von Hörsten S, Redrobe JP, Dumont Y, Quirion R (2002) The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 26(3):259–283. http://www.ncbi.nlm.nih.gov/pubmed/12034130

Article  CAS  PubMed  Google Scholar 

Khaleghi M, Rajizadeh MA, Bashiri H, Kohlmeier KA, Mohammadi F, Khaksari M, Shabani M (2021) Estrogen attenuates physical and psychological stress-induced cognitive impairments in ovariectomized rats. Brain Behav 11(5):e02139. https://doi.org/10.1002/brb3.2139

Article  CAS  PubMed  PubMed Central